The North America alopecia market size was valued at USD 2.88 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The increasing prevalence of alopecia coupled with the rising prevalence of autoimmune and other chronic disorders that... Read More »
June 2023The Arizona legal cannabis market size was valued at USD 485.7 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 17.3% from 2023 to 2030. Increasing burden of chronic pain and rising demand for effective pain management therapies are boosting the growth o... Read More »
June 2023The global alopecia market was valued at USD 8.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. One of the major growth driving factors for the market is the increasing awareness of alopecia, as people are becoming more consciou... Read More »
June 2023(CAGR) of 15.3% from 2023 to 2030. The growth of the U.S. cannabinoids industry is attributed to the increasing use of cannabinoids for the rising awareness about their health and therapeutic benefits... Read More »
June 2023The global plant-based API market size was estimated at USD 27.97 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2023 to 2030. The plant-based API market is witnessing growth due to factors such as the rising awareness... Read More »
June 2023The Morocco medical cannabis market size was valued at USD 24.90 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 48.0% from 2023 to 2030. The growth of the industry in the country is driven by several factors, including the increasing legalization of me... Read More »
June 2023The global analgesics market size was valued at USD 38.60 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.02% from 2023 to 2030. Increasing incidences of arthritis & osteoarthritis, neuropathic diseases, and cancer are expected to boost market gro... Read More »
June 2023The California legal cannabis market size was valued at USD 2.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.2 % from 2023 to 2030. The growth is attributed to the rising awareness regarding the use of cannabis products for pain management therapies. According to a study publ... Read More »
May 2023The Colorado legal cannabis market size was valued at USD 864.4 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 16.3% from 2023 to 2030. The growth is attributed to the rising increasing technological advancement coupled with ease of access to cannabis ... Read More »
May 2023The global biologics market size was valued at USD 461.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.3% from 2023 to 2030. Rising burden of cancer, genetic diseases, and autoimmune diseases coupled with the approval of several disease-modifying ... Read More »
May 2023Rise in rare diseases, beneficial government policies, and exclusive market access for orphan drug manufacturers fuel the expansion of the orphan drugs market. Nevertheless, the limited availability of patients for clinical trials and product promotion and the high expenses associated wi...Read More »
The global antibiotic resistance market size was valued at USD 8.13 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030. The increasing burden of antibiotic-resistant infections across developed & developing regions and a shift in... Read More »
May 2023The U.S. platelet rich plasma market size was valued at USD 222.73 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030. Platelet-rich Plasma (PRP) therapy has proven effective and safe in various medical applications, offering benefi... Read More »
May 2023The global antibody drug conjugates market size was valued at USD 7.82 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2023 to 2030. The market is primarily driven by rising incidence of cancer globally. According to Cancer Research UK estima... Read More »
May 2023The Southeast Asia medical foods market size was valued at USD 1.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2030. According to the World Health Organization, the aging population in Southeast Asia is overgrowing. ... Read More »
May 2023The global enteral feeding formulas market size was valued at USD 6.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2023 to 2030. A rise in the prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, chronic liv... Read More »
May 2023The global cancer supportive care drugs market size was valued at USD 13.64 billion in 2022 and is expected to decline with a compound annual growth rate (CAGR) of -1.26% from 2023 to 2030. The approval and uptake of targeted drugs, which have lesser side effects than traditional chemotherapy drugs, and the launch o... Read More »
May 2023The global intravenous iron drugs market size was valued at USD 2.92 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. The increasing prevalence of chronic kidney disease, inflammatory bowel disease, and cancer, which are key targe... Read More »
May 2023The global intravenous immunoglobulin market size was estimated at USD 11.98 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. The growing geriatric population, rising prevalence of immunodeficiency diseases, increasing adoption of... Read More »
May 2023The global nanomedicine market size was valued at USD 174.13 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.57% from 2023 to 2030. Significant developments and recent commercialization of products, such as mRNA and liposome-based vaccines are expect... Read More »
May 2023The global excipients market size was estimated at USD 9.51 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.03% from 2023 to 2030. Increasing usage of generic medicines and rising demand for multifunctional excipients is expected to be key factors dri... Read More »
May 2023The global meningococcal vaccines market size was valued at USD 3.28 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.0% from 2023 to 2030. The increasing prevalence of meningitis is one of the major factors expected to drive the market... Read More »
May 2023The global women’s health market size was valued at USD 41.35 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. Market growth can be attributed to the increase in the geriatric population of women and introduction of new prod... Read More »
May 2023The global muscle relaxant drugs market size was valued at USD 3.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.38% from 2023 to 2030. The term "muscle relaxant" is typically used to describe medications that relax the skeletal muscles by acting o... Read More »
May 2023The global uterine fibroid treatment drugs market size was estimated at USD 1.80 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2030. The major factors driving the market growth are the increasing number of new product launches and t... Read More »
May 2023Sleep disorders can disrupt the natural sleeping patterns and cause symptoms such as daytime sleepiness, affecting a person's daily routine, weight, mental health, and relationships, and even leading to heart disease and diabetes. The common symptoms of sleep disorders include difficulty...Read More »
The global postmenopausal osteoporosis treatment market size was valued at USD 9.12 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. Sedentary lifestyles and unhealthy eating & drinking patterns that have an effect on women&rs... Read More »
May 2023Prothrombin Complex Concentrate (PCC) is a medication that treats bleeding disorders resulting from deficiencies in coagulation factors II, VII, IX, and X. It is derived from human plasma and has concentrated coagulation factors. Administered intravenously, PCC quickly replenishes the co...Read More »
The global peptide therapeutics market size was valued at USD 42.05 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2030. The rising incidence of cancer as well as metabolic disorders such as osteoporosis, obesity, and diabetes will dr... Read More »
May 2023The global nuclear medicine market size was estimated at USD 9.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.8% from 2023 to 2030. The market is witnessing growth due to the presence of a robust product pipeline and favorable government initiativ... Read More »
May 2023The global hormone replacement therapy market size was valued at USD 21.28 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 6.6% from 2023 to 2030. The hormone replacement therapy (HRT) market is witnessing growth due to factors such as the rising inci... Read More »
May 2023The global cancer immunotherapy market size was valued at USD 115.01 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Increasing prevalence of oncology across the globe coupled with a surge in R&D efforts for the development o... Read More »
May 2023The global cryotherapy market size was valued at USD 6.96 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030. Some of the major factors propelling the growth are rising demand for minimally invasive procedures, high prevalence of ski... Read More »
May 2023The global branded generics market size was estimated at USD 240.75 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030. Rising prevalence of chronic diseases, increasing penetration of branded generic drugs, increasing government ini... Read More »
May 2023The Europe active pharmaceutical ingredients (API) market size was estimated at USD 42.64 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The market is primarily driven by advancements in developing active pharmaceutical ingredi... Read More »
May 2023The global allergy diagnostics and therapeutics market size was estimated at USD 29.36 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. Some of the major factors driving the market growth are the rising prevalence of allergy disor... Read More »
May 2023The U.S. intravenous immunoglobulin market size was valued at USD 5.74 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. Some of the major factors propelling the U.S. IVIG market are the increase in demand for immunoglobulin repla... Read More »
May 2023The U.S. minor cannabinoids market size was valued at USD 9.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 16.4% from 2023 to 2030. The shift in the trend of adoption from conventional therapeutics to cannabinoid-derived therapeutics owing to affirma... Read More »
April 2023The global artemisinic acid market size was valued at USD 699.18 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.24% from 2023 to 2030. This growth can be attributed to the high incidence of malaria, especially in developing and under-developing econo... Read More »
April 2023The global crocin market size was estimated at USD 4.54 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.14% from 2023 to 2030. Some of the major factors driving the market are the rising prevalence of conditions like headaches, flu, & other pains,... Read More »
April 2023The global lactation support supplements market size was valued at USD 569.8 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. The growth can be attributed to the increasing childbirth rate coupled with the growing prevalence of in... Read More »
April 2023The growth of iron deficiency anemia (IDA) therapy market can be attributed to the increasing prevalence of disease due to the insufficient iron consumption, blood loss, an inability of the patient's body to absorb iron, and comorbid conditions among others. Women, infants, children, vegetarians, and frequent blood ...Read More »
Cancer vaccines are a type of immunotherapy that stimulates the immune system to recognize and attack malignant/tumorous cells. Increasing focus on personalized vaccines is among the key trend in the space. Personalized cancer vaccines are designed to target the unique genetic mutations ...Read More »
Over the counter (OTC) dry eye drops are non-prescription drops for eyes that can be purchased without a prescription from a doctor. The market is projected to grow due to the growing prevalence of dry eye disease (DED), rising demand for effective treatments, increasing awareness among ...Read More »
Dupuytren's disease, also known as dupuytren's, contractures, is the condition resulting in the disorder that causes the tissue in the palm to shorten and thicken, giving the fingers an impression of being clawed. It is a non-painful disease that prevents the affected fingers from fully ...Read More »
Glaucoma is a chronic eye disease characterized by damage to the optic nerve, which can lead to permanent vision loss if left untreated. As per BrightFocus Foundation report published in October 2022, there are more than 3 million Americans are living with the disease, out of which 2.7 m...Read More »
The global cannabis pharmaceuticals market size was valued at USD 1.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 62.5% from 2023 to 2030. Wide scale applications of cannabis in various medical applications are driving the market.... Read More »
April 2023The respiratory disease vaccine market is projected to grow at a lucrative rate over the forecast period due to rising healthcare infrastructure, growing awareness about vaccination, and growing geriatric population. Diseases that affect the lungs and other components of the respiratory ...Read More »
The growth of the adult vaccine market is attributed to rising demand for better healthcare infrastructure and the high degree of public awareness about the advantages of immunizations. Governments all throughout the world are working to guarantee that everyone in society, regardless of ...Read More »
The global plant-based excipients market size was estimated at USD 1,789.58 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.28% from 2023 to 2030. The market is witnessing growth due to factors such as the regulatory support, rising R&D for n... Read More »
April 2023Microorganisms conduct fermentation and create secondary metabolites. Adjustments in growth environments can be used to make these organisms covert economical carbon sources (starch, sucrose, glucose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into ...Read More »
The global gabapentin market size was estimated at USD 2,022.84 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.35% from 2023 to 2030. The growth can be attributed to factors such as the increasing incidence of neuropathic pain and seizures and the ... Read More »
March 2023The global clinical laboratory tests market size was estimated at USD 103.67 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. The clinical laboratory tests market is witnessing growth due to factors such as the rising geriatric ... Read More »
March 2023The global gastroesophageal reflux disease therapeutics market size was estimated at USD 5.18 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 1.76% from 2023 to 2030. The GERD treatment market is witnessing growth due to factors such as the low succes... Read More »
March 2023The global high potency active pharmaceutical ingredients market size was estimated at USD 25.17 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. High potency active pharmaceutical ingredients (HPAPI) market is witnessing growth... Read More »
March 2023The U.S. medical foods for orphan disease market size was valued at USD 339.4 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% over the forecast period from 2023 to 2030. The market is driven by various factors such as increasing awareness about o... Read More »
February 2023The global substance abuse treatment market size was estimated at USD 10.25 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.05% from 2023 to 2030. The industry is witnessing rapid growth due to factors, such as the rising awareness about the tr... Read More »
February 2023The global oral clinical nutrition market size was valued at USD 15.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. The rising prevalence of malnutrition among the adult population and increase in the instances of obesity, ri... Read More »
February 2023The global women’s health and beauty supplements market size was valued at USD 53.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2030. The rise in the health-consciousness among people is anticipated to propel the growth. In... Read More »
February 2023The global liver metastases treatment market size was valued at USD 1.32 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030. This can be attributed to the rising incidence of the target disease. According to the National Library of... Read More »
February 2023The Missouri legal cannabis market size was valued at USD 512.1 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 23.0% from 2023 to 2030. The growing disease burden of chronic pain and the increasing requirement for pain management therapies across the... Read More »
February 2023Peanut allergy is witnessing a rise in prevalence burden in the last decade. According to Food Allergy Research & Education, about 32 million general population suffer from disease in the U.S., of which 6.1 million patients are allergic to peanuts. Along with increasing prevalence, t...Read More »
Aspergillosis treatment market is expected to grow at a moderate CAGR during the forecast period. Increasing prevalence of target disease and increasing focus on the development of novel drugs is expected to positively contribute to market growth. According to Center for Disease Control ...Read More »
The global tuberculosis therapeutics market size was estimated at USD 2.01 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.09% from 2023 to 2030. The growth is due to factors such as the rising prevalence of tuberculosis, increasing investments in h... Read More »
February 2023The global erythropoietin drugs market was valued at USD 6.87 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2023 to 2030. The introduction of biosimilar EPO in the U.S. market in 2018, the impending patent expiry of Aranesp in 2024 in... Read More »
February 2023The global inflammatory bowel disease treatment market size was valued at USD 20.33 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.6% by 2030. The rising prevalence of ulcerative colitis and Crohn’s disease across the globe is anticipated to ... Read More »
February 2023The global radiation oncology market size was valued at USD 8.65 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.3% from 2023 to 2030. Key factors driving the market include technological advancement in radiotherapy equipment, global rise in cancer... Read More »
February 2023The global retinal disorder treatment market size was estimated at USD 12.57 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. The retinal disorder treatment industry is witnessing growth due to factors such as the growing incide... Read More »
February 2023The global onychomycosis market size was estimated at USD 3.44 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.56% by 2030. The onychomycosis market is witnessing growth due to factors such as the rising incidence of onychomycosis and chronic diseas... Read More »
February 2023The global generic pharmaceuticals market was valued at USD 361.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The growth can be attributed to the number of ANDA approvals and launches of generic drugs products is increasing... Read More »
February 2023The global cannabis cultivation market was valued at USD 392.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.3% from 2023 to 2030. Growing legalization and the adoption of cannabis for the treatment of chronic diseases are the key factors driving... Read More »
February 2023The global biomarkers market size was valued at USD 66.97 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.3% from 2023 to 2030. The increasing significance of companion diagnostics, a rise in the prevalence of cancer, and increasing investments in ... Read More »
January 2023The global oncology based in-vivo CRO market size was valued at USD 1.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. The increasing frequency of outsourcing of R&D activities by major pharmaceutical companies to focus on... Read More »
January 2023The global complementary and alternative medicine market size was valued at USD 117,210.3 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.1% from 2023 to 2030. The market is expected to gain traction in the coming years as a result of the changing regulatory landscape and robu... Read More »
January 2023The U.S. actinic keratosis treatment market size was valued at USD 2.32 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.03% from 2023 to 2030. The increasing prevalence of actinic keratosis, the increased risk of developing skin cancer, and the surg... Read More »
January 2023The U.S. and Europe pharmaceutical manufacturing market was valued at USD 378.51 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.81% from 2023 to 2030. The introduction of novel technologies, adoption of more efficient & cost-effective manufacturi... Read More »
January 2023The global bronchodilators market size was estimated at USD 22.19 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.29% by 2030. The bronchodilators market is witnessing growth due to factors such as the growing geriatric population, increasing preval... Read More »
January 2023The global hearing loss disease treatment market size was valued at USD 12.71 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.92% from 2023 to 2030. The increasing prevalence of hearing loss, rising age-related sensorineural degeneration, and rising a... Read More »
December 2022The global influenza vaccine market size was valued at USD 7.28 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.83% from 2023 to 2030. The rise in the incidences of seasonal influenza and increasing recommendations for vaccination against the disease ... Read More »
December 2022The global biodefense market size was valued at USD 15.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. Biodefense is a set of medical or military measures. These are taken in response to the demand for restoring the biosecuri... Read More »
December 2022The global astaxanthin market size was valued at USD 1,943.12 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 17.2% from 2023 to 2030. The increase in demand for astaxanthin from various end-use applications such as nutraceuticals, cosmetics, pharmace... Read More »
December 2022The Middle East complementary and alternative medicine market size was valued at USD 8,176.4 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20.18% from 2023 to 2030. Complementary and alternative medicine (CAM) is commonly used in the Middle East as ... Read More »
December 2022The global infertility drugs market size was valued at USD 3,480.14 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The market players are engaged in introducing novel medicines for treating infertility.... Read More »
December 2022The global minimal residual disease testing market was estimated at USD 1.89 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.45% from 2023 to 2030. The minimal residual disease testing market is witnessing growth due to factors such as the increasi... Read More »
December 2022The India molecular diagnostics market size was valued at USD 934 million in 2022 and is expected to decline at a compounded annual rate of -7.49% from 2023 to 2030. The rising target disease burden, growing geriatric population, and introduction of technologically advanced products... Read More »
December 2022The Europe branded generics market size was valued at USD 38.96 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The rising prevalence of chronic diseases across the region is expected to contribute to market growth. The increas... Read More »
December 2022The global population screening market was estimated at USD 25.18 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.36% from 2023 to 2030. The market is witnessing growth due to factors such as the increasing prevalence of chronic and non-communicable... Read More »
December 2022The global omics lab services market size was estimated at USD 69,381.85 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.72% by 2030. The omics lab services market is witnessing growth due to the factors such as increasing demand/adoption for the s... Read More »
December 2022The global autism spectrum disorder treatment market size was valued at USD 2.05 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The research and development of novel medicines to treat patients with autism spectrum disorder (A... Read More »
December 2022The global laboratory developed tests market size was valued at USD 10.04 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.58% by 2030. The industry is witnessing growth due to the factors, such as increasing demand for in vitro diagnostic tests that... Read More »
December 2022The global gastrointestinal therapeutics market size was valued at USD 37.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.3% from 2023 to 2030. The increasing prevalence of gastrointestinal disorders such as IBS, Crohn’s disease, and ulcerat... Read More »
December 2022The global endometriosis treatment market size was valued at USD 1,222.2 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2023 to 2030. The rising disease burden, increasing disease awareness, and robust product pipeline are among the major ... Read More »
November 2022The global diagnostic enzymes market size was estimated at USD 4.92 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.97% by 2030. The diagnostic enzymes market is witnessing growth due to the factors such as the increasing prevalence of infectious di... Read More »
November 2022The global attention deficit hyperactivity disorder market size was valued at USD 13.21 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030. The rising prevalence of ADHD across the globe is expected to contribute to market gro... Read More »
November 2022The global peptide drug conjugates market size was valued at USD 596.27 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.58% from 2022 to 2030. The robust clinical trial pipeline with peptide drug conjugates (PDCs) coupled with increase in R&D i... Read More »
November 2022The global vulvovaginal candidiasis treatment market size was valued at USD 986.5 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.39% from 2022 to 2030. According to an NCBI article, VVC is a common infection among women affecting around 138 million w... Read More »
November 2022The global post-traumatic stress disorder treatment market size was valued at USD 915.5 million in 2021 and is expected to witness a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. The major factor driving the market includes robust late stage product pipeline and increasin... Read More »
November 2022The global medical foods for orphan diseases market size was valued at USD 1.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2023 to 2030. Increasing prevalence of rare diseases, healthcare expenditure, early screening, and awareness about... Read More »
November 2022The global head and neck cancer therapeutics market size was valued at USD 1.22 billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 12.5% from 2022 to 2030. The increasing prevalence of head and neck cancer is anticipated to fuel market growth.... Read More »
November 2022The global spinal muscular atrophy treatment market size was valued at USD 3,882.0 million in 2021 and is expected to witness a compounded annual growth rate (CAGR) of 18.6% from 2022 to 2030. The market is primarily driven by rising incidence of spinal muscular atrophy (SMA). According ... Read More »
November 2022The global sports nutrition market size was valued at USD 42.9 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. Nutrition and diet are essential for maximum performance. Sports nutrition products offer benefits, such as optimal ... Read More »
November 2022The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. The increasing geriatric population, which is exposed to a high risk of developing Parkinson&rsq... Read More »
November 2022The global atopic dermatitis drugs market size was valued at USD 12.71 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.0% from 2022 to 2030. Growing prevalence of atopic dermatitis, strong pipeline, emergence of biologics, and untapped opportun... Read More »
October 2022The global actinic keratosis treatment market size was valued at USD 6.22 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030. The market is anticipated to witness growth opportunities owing to factors such as rising prevalence of a... Read More »
October 2022The Thailand legal cannabis market size was valued at USD 80.3 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 58.4% from 2022 to 2030. The growth can be attributed to cannabis legalization and its rising usage for medical purposes. Cannabis compounds... Read More »
October 2022The global clinical laboratory service market size was estimated at USD 217.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030. The industry is witnessing growth due to factors, such increasing burden of chronic diseases and the... Read More »
October 2022The global ophthalmic drugs market size was valued at USD 33.81 billion in 2022 and is expected to witness a compound annual growth rate (CAGR) of 7.80% from 2023 to 2030. Increasing research and development activities to develop and launch novel ophthalmic drugs, and various strategic i... Read More »
October 2022The global opioids market size was valued at USD 22.66 billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 1.2% from 2022 to 2030. Increasing approval and launch of new opioid medicines to treat patients with chronic pain are the factors expected to dri... Read More »
October 2022The global congestive heart failure drugs market size was valued at USD 6.15 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.60% from 2022 to 2030. The market is witnessing growth due to a robust product pipeline, a rising geriatric population, and... Read More »
October 2022The global prostate cancer therapeutics market size was estimated at USD 12.12 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030. The market is witnessing growth due to the factors such as the increasing prevalence of pr... Read More »
October 2022The global non-alcoholic steatohepatitis biomarkers market size was estimated at USD 982.15 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 23.6% from 2023 to 2030. Non-alcoholic Steatohepatitis (NASH) biomarkers market is witnessing growth due t... Read More »
October 2022Carbapenem market is majorly driven by the rising prevalence of infectious diseases such as urinary tract infections (UTIs), intra-abdominal infections, & bacterial meningitis and the increasing movement of generic product companies. Urinary tract infections (UTIs) are one of the mos...Read More »
Retinal Vein Occlusion (RVO) is a condition where blockage of central and branch retinal veins that are important for the supply of blood to the center for pumping and purification. Vein blockage causes vision loss. Several factors have been identified as being associated with RVO condit...Read More »
The global herpes simplex virus treatment market size was valued at USD 1.54 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.24% from 2023 to 2030. The growth can be attributed to growing burden of herpes simplex virus infection, including oral herp... Read More »
October 2022The global non-opioid pain treatment market size was valued at USD 38.64 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030. The growth of the industry can be attributed to the increasing R&D investments by the key players for ... Read More »
October 2022The global postpartum health supplements market was valued at USD 1.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. The increasing prevalence of postnatal depression and the introduction of innovative products by the key play... Read More »
September 2022The global monkeypox vaccine and treatment market size was valued at USD 85.23 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.16% from 2022 to 2030. Factors such as the increasing incidence of monkeypox infection across the globe and the rising de... Read More »
September 2022The global transthyretin amyloidosis treatment market size was valued at USD 4.72 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030. The growth is attributed to the extensive research in the development of new therapies and the pr... Read More »
September 2022The global synthetic small molecule API market size was valued at USD 131.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.73% from 2022 to 2030. The growth of the market is attributed to factors such as the growing demand for small molecules API ... Read More »
September 2022The global protein expression market size was valued at USD 2.78 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. The increasing importance of protein-based therapeutics in modern medicine coupled with the growing investment by... Read More »
September 2022The global bone and joint health supplements market size was valued at USD 2.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2022 to 2030. The rapidly growing geriatric population, increasing prevalence of orthopedic disorders, and rising... Read More »
September 2022The global dry eye syndrome treatment market size was valued at USD 5.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.85% from 2023 to 2030. The market is witnessing growth due to the factors such as the growing demand for effective treatments, t... Read More »
August 2022The global stomach cancer treatment market size was valued at USD 3.83 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.9% from 2022 to 2030. Gastric cancer is one of the leading causes of cancer-related deaths and the fifth most common malignancy w... Read More »
August 2022The global antibody fragments market size was valued at USD 7.14 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030. Fragment antibodies are a promising tool in diagnostic and imaging as they are capable of identifying cellular pro... Read More »
August 2022The global age-related macular degeneration market size was valued at USD 9.84 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2030. The launch of new products for the treatment of age-related macular degeneration (AMD), rise in AMD ... Read More »
August 2022The global rehabilitation robots market was valued at USD 226.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.3% from 2022 to 2030. The growth can be attributed to the rising per capita healthcare spending and rapid adoption of technologically ad... Read More »
August 2022The global inhalation and nasal spray generic drugs market size was valued at USD 17.50 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.96% from 2022 to 2030. The market is primarily driven by the rising incidence of chronic respiratory diseases glo... Read More »
August 2022The global paracetamol IV market was valued at USD 700.24 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.97% from 2022 to 2030. The market is driven by the increasing use of paracetamol IV in reducing pain and relieving fever in post-surg... Read More »
August 2022The global rare diseases treatment market size was valued at USD 119.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.8% from 2022 to 2030. The presence of a strong product pipeline and the imminent launches are expected to fuel market growth... Read More »
August 2022The growth of the herpes infection treatment market is attributed to an increasing prevalence of herpes infection globally and growing awareness about the disease. For instance, according to WHO, in 2020, nearly 50 million of the population were suffering from genital herpes caused by ty...Read More »
The global diabetic foot ulcer treatment market size was valued at USD 4.67 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030. Diabetes is one of the most common health conditions across the globe and affects nearly 537 million ad... Read More »
August 2022The global cannabis extract market size was valued at USD 3.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20.0% from 2023 to 2030. Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for ... Read More »
August 2022The global microbiome therapeutics market size was valued at USD 94.86 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 35.32% from 2023 to 2030. The market is witnessing growth due to the factors such as the increasing number of strategic collabo... Read More »
August 2022The global non-alcoholic steatohepatitis treatment market size was valued at USD 1.04 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 39.2% from 2022 to 2030. The non-alcoholic steatohepatitis (NASH) treatment market is witnessing growth due impending... Read More »
August 2022The global omega 3 prescription drugs market size was valued at USD 1.23 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.27% from 2022 to 2030. The key factors boosting the industry growth are increasing cases of Cardiovascular Diseases (CVDs), obesit... Read More »
August 2022The global medical marijuana market size was valued at USD 11.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 21.06% from 2022 to 2030. The industry is experiencing growth due to the rising awareness regarding various therapeutic applications of the... Read More »
August 2022The global immunotherapy drugs market size was valued at USD 110.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.92% from 2022 to 2030. The market is primarily driven by the rising incidence of chronic diseases globally. The International Diabete... Read More »
July 2022The global kidney cancer drugs market size to be valued at USD 6.3 billion by 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period. The U.S. dominated the scene among the seven major markets. Market growth is largely driven by factors su... Read More »
July 2022The global erectile dysfunction drugs market was valued at USD 2,296.01 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2022 to 2030. The increasing burden of lifestyle diseases and the rising adoption of a sedentary lifestyle are responsibl... Read More »
July 2022The global urothelial cancer drugs market size to be valued at USD 3.6 billion by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 22.9% during the forecast period. The U.S. held the dominant share among the seven major markets. Market growth is largely attributed ... Read More »
July 2022The global narcolepsy therapeutics market size to be valued at USD 3.85 billion by 2025. The market is expected to grow substantially owing to the rising incidence across the globe. Narcolepsy is generally a lifelong sleep disorder with occurrence of sudden uncontrollable sleep attacks a... Read More »
July 2022The global pancreatic cancer treatment market size to be valued at USD 4.2 billion in 2025. The rising prevalence of obesity, alcohol consumption, and smoking is expected to propel the market growth. In addition, growing geriatric population is expected to drive the growth of the pancrea... Read More »
July 2022The global topical drugs market size was valued at USD 97.42 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. The industry growth is primarily driven by the rising incidence of skin disorders and diabetes. According to the Britis... Read More »
July 2022The global CBD oil & CBD consumer health market size to be valued at USD 123.2 billion by 2027 and is expected to grow at a compound annual growth rate (CAGR) of 25.6% during the forecast period. Increasing the adoption of cannabidiol (CBD) and infused products for various medical an... Read More »
July 2022The global drug and gene delivery devices market size to be valued at USD 786.9 Billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 7.7% during the forecast period. Growing efforts towards formulating dosage forms that would help in maximizing the bioavaila... Read More »
July 2022The global peptide antibiotics market size was valued at USD 4.37 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2022 to 2030. The factors responsible for driving the growth of the market are increasing demand of peptide antibiotics in hosp... Read More »
July 2022The global Alzheimer's therapeutics market size was valued at USD 4.04 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.2% from 2022 to 2030. The rising prevalence of Alzheimer’s disease and approval of disease-modifying therapies are expected... Read More »
July 2022The global HPV associated disorders market size to be valued at USD 23.2 billion by 2026 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% during the forecast period. The growing prevalence of HPV-related diseases and increasing penetration of treatment options are ... Read More »
July 2022The global specialty generics market size was valued at USD 69.90 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 9.9% from 2023 to 2030. Increasing adoption of specialty generic medicines for the treatment of complex chronic diseases such as hepatiti... Read More »
July 2022The global heparin market size was valued at USD 7.42 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 2.5% from 2023 to 2030. The increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism is anti... Read More »
July 2022The global local anesthesia drugs market size to be valued at USD 6.45 billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 3.7% during the forecast period. There has been an increase in the number of surgical procedures performed across the globe, including... Read More »
July 2022The global non-steroidal anti-inflammatory drugs market size was valued at USD 19,551.34 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.36% from 2022 to 2030. The growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market is owing to facto... Read More »
July 2022The global insulin market size was estimated at USD 20.35 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2022 to 2030. The insulin market is witnessing growth due to factors such as the increasing incidence of diabetes and formulation advan... Read More »
July 2022The North America OTC health products market size was estimated at USD 62.88 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.04 % from 2022 to 2030. The growth can be attributed to factors such as growing consumer awareness, increasing consumer will... Read More »
July 2022The global small molecule API market size was valued at USD 175.31 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.44% from 2022 to 2030. Some of the major factors propelling the market are the growing demand for small molecule drugs in the market ... Read More »
July 2022The global cellular immunotherapy market size was valued at USD 6.13 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 22.41% from 2022 to 2030. Some of the major factors propelling the market growth are the development of advanced cell-based therapies... Read More »
July 2022The global pharmaceutical contract packaging market size to be valued at USD 47.7 billion by 2027 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during the forecast period. Increasing stringent quality requirements and outsourcing of pharmaceutical packaging to c... Read More »
July 2022The North America legal marijuana market size was valued at USD 13.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2023 to 2030. Across North America, cannabis legitimization has brought about a massive change in the market... Read More »
June 2022The global aminoglycosides market size to be valued at USD 1.68 billion by 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.5% during the forecast period, owing to rising incidence of bacterial infections caused by gram-positive and gram-negative bacteria. Usage ... Read More »
June 2022The global antiviral drugs market size to be valued at USD 60.0 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of (-0.6%) during the forecast period. The introduction of the generic version of antiviral medicines and growing awareness about the avail... Read More »
June 2022The global antipsychotic drugs market size was valued at USD 11.7 billion in 2015 and is expected to grow at a CAGR of 2.1% over the forecast period. Growing prevalence of psychosis and related diseases is driving the demand for antipsychotic drugs. The major factors contributing towards... Read More »
June 2022The Missouri medical cannabis market size was valued at USD 394.1 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.40% from 2023 to 2030. In Missouri, medical cannabis was legalized in November 2018. The factors contributing to market expansion... Read More »
June 2022The U.S. cannabis market size was valued at USD 13.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 14.2% from 2023 to 2030. In the United States, cannabis is often used in the cosmetic, pharmaceutical, and food & beverage industries. The increas... Read More »
June 2022The global mineral supplements market size was valued at USD 13.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 2.4% from 2022 to 2030. Growing adoption of mineral supplements to manage chronic conditions due to the large percentage of the populatio... Read More »
June 2022The Mexico medical cannabis market size was valued at USD 4.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20% from 2023 to 2030. Various countries have begun to liberalize marijuana and hemp regulations, which is expected to stimulate market growt... Read More »
June 2022The North America legal cannabis market size was valued at USD 15.2 billion in 2022 and is expected to rise steadily with a compound annual growth rate (CAGR) of 14.6% from 2023 to 2030. Cannabis was made illegal by the tax act passed in 1937, California was the first state to make canna... Read More »
June 2022The Australia legal cannabis market size was valued at USD 66.0 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 29.6% from 2023 to 2030. The growth of the market is propelled by the increasing public knowledge of the health benefits of cannabis intake... Read More »
June 2022The North America, Europe, and Asia Pacific legal cannabis market size was valued at USD 18.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2023 to 2030. On the economic front, recreational-use marijuana legalization will help create new job possibilities and add sig... Read More »
June 2022The Europe medical foods market size was valued at USD 5.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 2.9% from 2022 to 2030. The rise in the prevalence of chronic diseases, the rapidly growing geriatric population, and governmental authorities f... Read More »
May 2022The global active pharmaceutical ingredients market size was valued at USD 222.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.90% from 2023 to 2030. The growth can be attributed to the advancements in active pharmaceutical ingredient (API) manufa... Read More »
May 2022The global cannabidiol market size was valued at USD 5.18 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.8% from 2022 to 2030. Cannabidiol is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, g... Read More »
May 2022The global inhalation anesthesia market size was valued at USD 1.1 billion in 2021 and is projected to expand at a CAGR of 9.0% in the forecast period. The market growth can be attributed to the growing number of surgical procedures. Inhalation anesthesia facil... Read More »
May 2022The Asia Pacific medical foods market size was valued at USD 5.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030. The Asia Pacific (APAC) market is fairly untapped and rapid urbanization and development in the region have widene... Read More »
May 2022The Latin American nutritional supplements market size was valued at USD 48.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. The Latin American population has had a history of a high prevalence of chronic diseases like hyperte... Read More »
May 2022The global antifungal drugs market size was valued at USD 15.30 billion in 2022 and is projected to witness at a compound annual growth rate (CAGR) of 3.74% from 2023 to 2030. The growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors... Read More »
May 2022The global dermatological drugs market size was valued at USD 17.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2028. The key factors driving the global dermatological drug market are parasites, fungus, and other microorganisms living on the skin; bacteria t... Read More »
May 2022The global digestive & intestinal remedies market size was valued at USD 18.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2028. The market is majorly driven by high demand for over-the-counter products such as zientac, omez, ... Read More »
May 2022Latin America and Caribbean hemp-derived derived cannabidiol market was estimated at USD 112.33 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.6 % for the forecast period 2022 to 2030. Latin America and the Caribbean region has been a key region f... Read More »
April 2022The Europe, Middle East, and Africa sports nutrition market size was valued at USD 3.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. As opposed to earlier, when sports nutrition was targeted towards athletes, it has now becom... Read More »
April 2022The global nutritional supplements market size is expected to reach USD 358.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. Increasing awareness regarding health across the globe has markedly helped the market to thrive.... Read More »
April 2022The global legal marijuana market size was valued at USD 16.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.4% from 2023 to 2030. The growing demand for legal marijuana has been a primary factor in the growth of the market. Recently, a large numb... Read More »
April 2022The Europe nutrition and supplements market size was valued at USD 61.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. Europe's population has become more aware of health and fitness and has been increasingly adopting nutritio... Read More »
April 2022The Asia Pacific nutritional supplements market size was valued at USD 140.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030. The Asia Pacific region has been one of the forerunners in the nutritional supplements market. The pop... Read More »
April 2022The global legal cannabis market size was valued at USD 22.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2023 to 2030. The increasing rate of legalization of cannabis and acceptance of its use in the medical field are the key factors du... Read More »
April 2022The global huntington’s disease treatment market size was valued at USD 362.0 million in 2021 and is expected to expand a compound annual growth rate (CAGR) of 19.6% from 2022 to 2030. The expected label expansion of Ingrezza for treating chorea associated with Huntington’s d... Read More »
February 2022The Brazil sports nutrition market size was valued at USD 942.3 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. There is a growing prevalence of various lifestyles diseases such as diabetes, cardiovascular diseases, and obesity... Read More »
February 2022The global parenteral nutrition market size was valued at USD 6.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2030. Development of technically advanced parenteral nutrition products with barcode assistance, growing preference for ... Read More »
February 2022The global medical foods market size was valued at USD 22.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030. The growing prevalence of communicable and non-communicable diseases and increasing effort for the dietary management o... Read More »
January 2022The global bioanalytical testing services market size was estimated at USD 3,937.2 million in 2022 and is anticipated to register a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. The bioanalytical testing method is used for the quantitative determination of drugs or m... Read More »
January 2022The global pulmonary arterial hypertension market size was valued at USD 7.3 billion in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 5.32% from 2023 to 2030. Growing initiatives by key market players, high prevalence of pulmonary arterial hypertension, adoptio... Read More »
January 2022The global complementary and alternative medicine for anti aging & longevity market size was valued at USD 36.89 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% from 2021 to 2028. The rising aging population and diseases associated with it a... Read More »
January 2022The global pharmacy market size was valued at USD 1,008.5 billion in 2020 and is projected to expand at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028. The increasing number of people suffering from diseases, increasing aging population, and growing number of prescription... Read More »
January 2022The Europe complementary and alternative medicine market size was valued at USD 27.44 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 20.89% from 2021 to 2028. Complementary and alternative medicine (CAM) is considered a traditional treatment and the ... Read More »
December 2021The North America sports nutrition market size was valued at USD 12.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2028. Increasing awareness about the health benefits of consuming sports nutrition products among bodybuilders and ... Read More »
November 2021The global weight loss supplements market size was valued at USD 33.4 billion in 2020 and is projected to expand at a compound annual growth rate (CAGR) of 16.6% from 2021 to 2028. The rising cases of obesity and related health ailments, such as Cardiovascular Diseases (CVDs), diabetes, ... Read More »
November 2021The Europe pharmaceutical market size was valued at USD 282.75 billion in 2020 and is expected to expand at a compound annual growth rate(CAGR)of 5.4% from 2021 to 2028. The growth can be attributed to theincreasing healthcare expenditure, a surge in R&D investments, and the emergenc... Read More »
October 2021The global shingles vaccine market size was valued at 2.99 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.9% from 2021 to 2028. The increased risk of developing shingles, especially in adults aged 60 and above, and improvement in healthcare policie... Read More »
October 2021The global immune health supplements market size was valued at USD 55.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028. The key factors driving market growth include the increasing prevalence of infectious diseases, diabetes, ... Read More »
September 2021The global sodium hyaluronate-based products market size was valued at USD 8.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028. The growth of the market can be attributed to an increase in the geriatric population, a demographic... Read More »
September 2021The global anti-vascular endothelial growth factor therapeutics market size was valued at USD 11.67 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 0.5% from 2021 to 2028. The anti-Vascular Endothelial Growth Factor (VEGF) therapeutics market growth can... Read More »
September 2021The North America and Europe medical foods market size was valued at USD 11.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028. Some of the drivers of the market are the rising geriatric population, the increasing prevalence of c... Read More »
September 2021The global glioblastoma multiforme treatment market size was valued at USD 2.14 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The growing prevalence of glioblastoma multiforme, increasing R&D, and favorable regulatory sce... Read More »
September 2021The Indiana homecare enteral feeding formula market size was valued at USD 70.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2021 to 2028. The demand for enteral feed formulations, such as the growing geriatric population and the rising p... Read More »
August 2021The global pharmaceutical cleaning validation market size was valued at USD 14.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2021 to 2028. The rapid growth of pharma manufacturing facilities, the rising prevalence of diseases, the growin... Read More »
August 2021The global pharmaceutical manufacturing market size was valued at USD 405.52 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028. The pharmaceutical landscape has undergone a massive transformation with the emergence of new technolo... Read More »
July 2021The global COVID-19 vaccine development tools market size was valued at USD 16.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. The market is expected to maintain its momentum in the coming future, attributive to the heavy inf... Read More »
July 2021The Tunisia pharmaceutical market size was estimated at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.9% from 2021 to 2028. The market is driven by the presence of various developed and integrated facilities that promote R&D, producti... Read More »
June 2021The global B2B sports nutrition market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.8% from 2021 to 2028. The rising demand for nutrition products in the form of protein bars, sports supplements, energy drinks, and othe... Read More »
May 2021The India large volume parenteral market size was valued at USD 83.4 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028. An increase in local manufacturing of Large Volume Parenteral (LVP) is contributing to the growth of the marke... Read More »
May 2021The global advanced therapy medicinal products market size was valued at USD 7.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13.2% from 2021 to 2028. The emergence of Advanced Therapy Medicinal Products (ATMPs) has transformed the pharmaceutical i... Read More »
May 2021The global biopharmaceutical excipients market size was valued at USD 2.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028. Excipients play an essential role in biopharmaceuticals by helping the efficient binding of ingredients, ... Read More »
February 2021The global drug discovery informatics market size was valued at USD 2.39 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028. The drug discovery informatics market is set to gain momentum in the coming years due to advancements in hi... Read More »
February 2021The global anticoagulant reversal drugs market size was valued at USD 679.84 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.3% from 2020 to 2027. Approval and launch of new therapies, increasing prevalence of bleeding disorders, and rise in the in... Read More »
February 2021The global hospital acquired infections therapeutic market size was valued at USD 10.3 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 2.4% from 2020 to 2027. The high prevalence of HAIs, approval & launch of new therapies, and increasing R&D ... Read More »
February 2021The global hemoglobinopathies market size was valued at USD 7.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2021 to 2028. The rising prevalence of conditions such as sickle cell disease (SCD) and thalassemia, coupled with the presence o... Read More »
February 2021The global central nervous system therapeutic market size was valued at 116.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028. Advancements in diagnostics and therapeutics of central nervous system (CNS) diseases are expected to... Read More »
February 2021The global nicotine replacement therapy market size was valued at USD 44.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.3% from 2021 to 2028. The growth can be attributed to the growing number of technological advancements and the increasing num... Read More »
February 2021The global antibiotics market size was valued at USD 40.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. The rising prevalence of infectious diseases and supportive government legislation are the major drivers of the market. M... Read More »
February 2021The North America hemp-derived cannabidiol market size was valued at USD 1.7 billion in 2019. It is expected to expand at a compound annual growth rate (CAGR) of 27.7% from 2020 to 2027. The growing awareness and adoption of cannabidiol (CBD) for various health conditions are the key fac... Read More »
November 2020The global systemic scleroderma treatment market size was valued at USD 1.4 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2020 to 2027. The supplemental approvals for existing treatment options coupled with the emergence of first-in-class ... Read More »
November 2020The global castrate-resistant prostate cancer market size was valued at USD 8.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2020 to 2027. The rising prevalence of castrate-resistant prostate cancer, growing adoption of novel drugs, along... Read More »
November 2020The U.S. hormone replacement therapy market size was valued at USD 10.2 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. The rising incidence of various hormonal imbalance disorders and the increasing population of geriatric and... Read More »
November 2020The introduction of a safe and effective product by 2021 seems highly possible as multiple candidates have entered Phase II trials. Unprecedented research efforts, in terms of both speed and scale, by hundreds of research groups are anticipated to bring a fundamental and necessary change... Read More »
October 2020The global eye health supplements market size was valued at USD 1.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. The growing incidences of vision impairment and rising myopic population, particularly during the COVID-19 pand... Read More »
September 2020The global burn ointment market size was valued at USD 813.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. Favorable reimbursement policies, technological advancements, and the rising incidence of burn cases are some of the key... Read More »
September 2020The Germany pharmaceuticals market size was valued at USD 41.4 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2020 to 2027. Increasing patent applications that are focused on the development of novel drug delivery systems, new drugs, and form... Read More »
September 2020The Germany and Netherlands medical marijuana market size was valued at USD 977.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 13.0% from 2020 to 2027. Increasing the legalization and use of medical marijuana and its growing adoption for the treatmen... Read More »
September 2020The global CBD consumer health market size was valued at USD 8.2 billion in 2019 and is projected to expand at a compounded annual growth rate (CAGR) of 24.6% from 2020 to 2027. The leading factor attributed to the growth is the positive government reforms for the legalization of cannabi... Read More »
June 2020The global botanicals and acupuncture market size was valued at USD 38.97 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 19.78% from 2020 to 2027. Wide acceptance for the manufacturing of multicomponent drugs is expected to increase the penetration rat... Read More »
June 2020The global ankylosing spondylitis market size was valued at USD 4.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% from 2020 to 2027. The introduction of novel products, as well as the entry of biosimilars, is expected to drive market growth over ... Read More »
June 2020The GLP-1 receptor agonist market size was valued at USD 11.3 billion in 2019 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. Formulation advancements of GLP-1 receptor agonist coupled with the presence of a robust product pipeline is expecte... Read More »
June 2020The North and South America mineral supplement tablets market size was valued at USD 2.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2020 to 2027. Rising prevalence of diseases such as osteoporosis, anemia, cancer, and diabetes is boosting... Read More »
May 2020The global allergy immunotherapy market size was valued at USD 1.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2020 to 2027. The anticipated growth in revenue can be attributed to the rising prevalence of allergic disorders and their burde... Read More »
May 2020The COVID-19 outbreak caused due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), affecting millions of people globally. The outbreak of the pandemic COVID-19 has impelled the pharmaceutical industry into action, with a race to develop both therapeutic and preventive inte...Read More »
The global hemophilia market size was valued at USD 11.8 billion in 2019 and is expected to witness a CAGR of 5.5% over the forecast period. Increasing R&D initiatives especially on identifying therapeutic agents is one of the major factors expected to positively impact market growth... Read More »
March 2020The global human growth hormone market size was valued at USD 4.6 billion in 2019 and is estimated to register a CAGR of 8.2% over the forecast period. Factors such as investments by market players, the presence of a strong pipeline, extensive R&D activities, robust product portfolio... Read More »
February 2020The global CBD nutraceuticals market size was valued at USD 3.8 billion in 2018 and is expected to expand at a CAGR of 18.8% over the forecast period. Growing consumer preference for plant-based supplements, awareness regarding medical benefits of cannabidiol including its remedial prope... Read More »
December 2019The Mexico hemp CBD market size was valued at USD 47.1 million in 2019 and is expected to grow at a significant rate over the forecast period. Key factors attributing to the market growth are favorable government policies that contributed to the increasing adoption of hemp-derived produc... Read More »
December 2019The global liver health supplements market size was valued at USD 707.16 million in 2018 and is expected to register a CAGR of 4.32% during the forecast period. In recent years, changing lifestyle pattern has led to a rise in the consumption of fast food and alcohol, contributing to the ... Read More »
December 2019The global Hunter syndrome treatment market size was valued at USD 864.9 million in 2018 and is expected to witness attractive growth over the forecast period. Introduction of novel therapies, robust product pipeline, rising government initiatives, and increasing awareness regarding Hunt... Read More »
November 2019The global hyaluronidase market size was estimated at USD 648.11 million in 2018 and is projected to grow at a CAGR of 8.55% during the forecast period. Rising penetration across various application areas and the presence of several clinical studies to demonstrate the efficacy of the pro... Read More »
November 2019The global somatostatin analogs market size was valued at USD 5.5 Billion in 2018 and is expected to grow at a CAGR of 6.3% over the forecast period. Increasing prevalence of Neuroendocrine Tumors (NETs), acromegaly, Cushing syndrome, and other related diseases is expected to accelerate ... Read More »
October 2019The global myasthenia gravis (MG) treatment market size was estimated at USD 1.16 billion in 2018 and is anticipated to grow at a CAGR of 7.5% over the forecast period. The key factors driving this market include the rising adoption of immunotherapies, the approval of promising drugs, th... Read More »
October 2019The global organ transplant immunosuppressant drug market size was estimated at USD 4.64 billion in 2018 and is anticipated to grow at a CAGR of 3.3% over the forecast period. Increasing demand for transplantation and technological advancements in organ transplants & tissue engineeri... Read More »
October 2019The global neglected tropical disease (NTD) treatment market size was valued at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 5.5% over the forecast period. Formal recognition of NTDs in the Sustainable Development Goals (SDG), a United Nations Development P... Read More »
October 2019The global amyotrophic lateral sclerosis treatment market size was valued at USD 537.2 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2019 to 2026. Rising geriatric population, growing awareness about ALS, and increasing incidence rate a... Read More »
October 2019The global non-opioid pain patches market size was valued at USD 732.6 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of4.6% from 2019 to 2026. Global rise in chronic and acute pain related disorders and various benefits associated with non-opioid pa... Read More »
October 2019The global enzyme replacement therapy market size was valued at USD 6.74 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of7.7% from 2019 to 2026. The rising availability of enzyme replacement therapies, increasing awareness, and less stringent guidelines for rare diseases are ke... Read More »
October 2019The global skeletal dysplasia market size was valued at USD 2.5 billion in 2018 and is expected to exhibit a CAGR of 4.0% over the forecast period. Skeletal dysplasia includes around 400 conditions affecting bone development, including cartilage growth and neurological functioning. Accor... Read More »
October 2019The global inhalable drugs market size was valued at USD 25.0 billion in 2018 and is estimated to exhibit a CAGR of 6.3%during the forecast period. Increasing prevalence of respiratory diseases such as Chronic Obstructive Pulmonary Diseases (COPD), asthma, and cystic fibrosis is anticipa... Read More »
October 2019The global lymphoma treatment market size was valued at USD 11.7 billion in 2018 and is anticipated to grow at a CAGR of 9.5% over the forecast period. The growing uptake of premium-priced products such as immune checkpoint inhibitors, Keytruda, and Opdivo is driving the market. In addit... Read More »
October 2019The global food allergy diagnostics & therapeutics market size was valued at USD 2.69 billion in 2018 and is expected to grow at a lucrative CAGR of 7.4% over the forecast period. The rising prevalence of food allergy is anticipated to drive the market. Symptoms associated with the a... Read More »
September 2019The U.S. prostate cancer nuclear medicine diagnostics market size was valued at USD 172.2 million in 2018 and is estimated to expand at a CAGR of 10.7% during the forecast period. Rising incidence of prostate cancer is expected to impel the demand for early and accurate diagnosis of the ... Read More »
September 2019The global anterior uveitis treatment market size was valued at USD 276.78 million in 2018 and is expected to witness a CAGR of 5.4% over the forecast period. Rising incidence of anterior uveitis is majorly driving growth. This disease causes inflammation in anterior part of the uvea of ... Read More »
August 2019The global aromatherapy carrier oil market size was valued at USD 898.03 million in 2018 and is expected to grow at a lucrative CAGR of 10.0% over the forecast period. Increase in preference for plant extracted products is one of the major factors driving the market. Carrier oils are veg... Read More »
August 2019The New York cannabis market size was valued at USD 1.8 billion in 2018 and is estimated to register a CAGR of 14.7% over the forecast period. Use of cannabis has been legalized in the state of New York for medical purposes, while recreational use of cannabis is expected to be legalized ... Read More »
July 2019The global cold pain therapy market size was valued at USD 1.6 billion in 2018 and is expected to grow at a CAGR of 4.9% during the forecast period. Rising prevalence of orthopedic diseases and the increasing number of sports injuries have led to the high growth of the market. According ... Read More »
July 2019The global opioid use disorder market size was valued at USD 1.9 billion in 2018 and is anticipated to grow at a CAGR of 10.1% over the forecast period. An increase in the opioid epidemic in the U.S. coupled with the establishment of government policies to control the crisis is driving t... Read More »
July 2019The U.S. aromatherapy market size was valued at USD 469.93 million in 2018 and is anticipated to exhibit a CAGR of 9.1% over the forecast period. Growing awareness about the therapeutic benefits of essential oils is one of the primary drivers. Essential oils have varied applications. The... Read More »
July 2019The global interleukin inhibitors market size was estimated at USD 20.7 billion in 2018 and is expected to exhibit a CAGR of 17.4% during the forecast period. Growing prevalence of autoimmune diseases and increasing adoption of interleukin inhibitors are expected to drive the IL Inhibito... Read More »
July 2019The global hereditary angioedema therapeutic market size was valued at USD 2.3 billion in 2018. Growing cases of hereditary angioedema (HAE) globally is a key market driver. According to the National Organization for Rare Disorders (NORD), about 1-9 people per 100,000 population are affe... Read More »
July 2019The global irritable bowel syndrome treatment market size was valued at USD 1.5 billion in 2018 and is anticipated to exhibit a CAGR of 10.1% over the forecast period. Rising prevalence of target disease, coupled with increasing uptake of drugs for the same, is driving the market. Furthe... Read More »
July 2019The global tumor necrosis factor inhibitor drugs market size was valued at USD 40.4 billion in 2018 and is estimated to expand at a CAGR of 0.5% over the forecast period. The growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune d... Read More »
July 2019The global scleroderma therapeutics market size was valued at USD 1.60 billion in 2018 and is estimated to expand at a CAGR of 6.0% from 2019 to 2026. The market is mainly driven by the off-label use of drugs approved for its symptomatic indications, such as rheumatoid arthritis. Lack of... Read More »
July 2019The global phenylketonuria treatment market size was valued at USD 445.8 million in 2018 and is expected to register a CAGR of 11.0% from 2019 to 2026. The increasing prevalence of PKU across the globe is estimated to accelerate market growth. According to the Genetics Home Reference, 1 ... Read More »
July 2019The global uveitis treatment market size was valued at USD 493.91 million in 2018 and is expected to witness a lucrative CAGR of 5.8% over the forecast period. Rising incidence of uveitis is the major factor driving the growth. According to The College of Optometrists, the incidence of a... Read More »
July 2019The global idiopathic pulmonary fibrosis treatment market size was valued at USD 2.00 billion in 2018 and is estimated to expand at a CAGR of 12.7% over the forecast period. Increasing prevalence of idiopathic pulmonary fibrosis (IPF) and increasing geriatric population are the key drive... Read More »
July 2019The global psoriatic arthritis treatment market size was valued at USD 8.6 billion in 2018 and is estimated to expand at a CAGR of 10.1% over the forecast period. The promising pipeline, new product launches, increasing disease burden, and a significant rise in consumer awareness are som... Read More »
July 2019The global antisense & RNAi therapeutics market size was estimated at USD 1.09 billion in 2018 and is expected to witness a CAGR of 7.5% during the forecast period. Antisense technology provides the opportunity to manipulate the gene expression and this is being considered as an effe... Read More »
June 2019The global anti-infective agents' market size was valued at USD 111.1 billion in 2018 and is anticipated to expand at a CAGR of 3.4% during the forecast period. Extensive R&D efforts pertaining to the development of new drugs with high efficacy and potency against multi-drug resistan... Read More »
March 2019Global neglected tropical diseases drugs and vaccines market comprise diseases that affect largely developing countries but due to increased international migration, these diseases are now a concern in developed nations. The London Declaration, signed in 2012, aimed to bring in focus neg...Read More »
The global anti-aging services market size was valued at USD 23.45 billion in 2018. It is poised to expand at a CAGR of 5.3% over the forecast period. The market has been shaped by constantly changing customer demands. Since the majority of the customer base in the market has become soci... Read More »
February 2019The global acromegaly treatment market size was estimated at USD 1.2 billion in 2018 and is expected to exhibit a CAGR of 7.5% during the forecast period. Increasing incidence of the disease is contributing to the high demand for the advanced treatment options which further boost the dev... Read More »
February 2019The global breast cancer drugs market size was valued at USD 16.98 billion in 2017 and is expected to register at a CAGR of 10.7% over the forecast period. Rising prevalence of the disease along with emerging novel therapies are some of the major factors likely to drive the market. Early... Read More »
February 2019The global cold plasma market size was valued at USD 55.84 million in 2017 and is expected to register a CAGR of 15.2% over the forecast period. Demand for cold plasma is increasing due to its extensive usage in medical treatment. In addition, rising cases of Hospital-Acquired Infec... Read More »
January 2019The global epigenetics drugs and diagnostic technologies market size was valued at USD 5.24 billion in 2017 and is projected to expand at a CAGR of 19.7% over the forecast period. High prevalence of cancer and other chronic diseases along with rising geriatric population are some of the ... Read More »
January 2019The global metabolic disorder therapeutics market size was valued at USD 49.65 billion in 2017 and is expected to register a CAGR of 7.56% over the forecast period. Increasing demand for one-time therapies for metabolic disorders and the rising prevalence of lifestyle diseases are the ke... Read More »
January 2019The global Fabry disease treatment market size was valued at USD 1.57 billion in 2017. It is anticipated to progress at a CAGR of 9.6% over the forecast period. Expanding base of patients suffering from Fabry disease coupled with increased adoption of novel therapies such as chaperone tr... Read More »
January 2019The global antacids market size was valued at USD 5.83 billion in 2017 and is projected to expand at a CAGR of 3.9% over the forecast period. Changing dietary habits is one of the major factors expected to fuel growth during the forecast period. Increasing prevalence of Gastro-Esop... Read More »
January 2019The global rosacea treatment market size was valued at USD 1.5 billion in 2017. It is anticipated to register a CAGR of 6.8% over the forecast period. The market is consolidated in nature. Proactive government initiatives, advanced formulations, and high disease prevalence are some facto... Read More »
January 2019The U.S. chiropractic market size was valued at USD 12.26 billion in 2017. It is projected to expand at a CAGR of 4.32% over the forecast period. The market growth largely depends on the treatment adoption from the patients who prefer non-invasive treatment of chronic pains. Increasing p... Read More »
December 2018The global cervical cancer treatment market size was valued at USD 6.3 billion in 2017 and is anticipated to expand at a CAGR of 5.0% during the forecast period. Increased disease prevalence, proactive government initiatives, and advent of targeted therapies are the major factors contrib... Read More »
December 2018The global plasma protein therapeutic market size was valued at USD 22.5 billion in 2017 and is anticipated to expand at a CAGR of 4.8% during the forecast period. Approval of plasma products across multiple indications, increasing R&D activities, and high demand for advanced therape... Read More »
December 2018Global hyperhidrosis treatment market is anticipated to witness significant growth over the forecast period owing to the surge in the incidences of secondary hyperhidrosis condition globally. Rising incidences of secondary hyperhidrosis are associated with sedentary lifestyle, unhealthy ...Read More »
The global food allergy market is anticipated to witness noteworthy growth over the forecast period owing to an alarming rise in the number of food allergies and sensitivities around the globe. Food allergy is an abnormal response caused by food products such as tree nuts, peanut, soy. T...Read More »
The global pompe disease market is expected to witness significant growth through the forecast period. Pompe disease (glycogenosis type II) is a rare disorder affecting approximately 1 in 40,000 people in the U.S. Factors such as continued uptake of long-term therapies, the launch of nov...Read More »
The global herbal supplements market size was valued at USD 5.26 billion in 2017 and is anticipated to grow at a CAGR of 6.2% over the forecast period. Some of the key factors contributing to the market growth are rising inclination towards natural products, awareness regarding preventiv... Read More »
November 2018The global acute repetitive seizures market size was estimated at USD 140.5 million in 2017 and is expected to register a CAGR of 47.8% over the forecast period. High unmet clinical needs for patients, as well as caregivers, and availability of advanced product pipeline are some of the m... Read More »
November 2018The global ADME toxicology testing market size was valued at USD 4.33 billion in 2017 and is expected to register a CAGR of 11.4% over the forecast period. A rising number of drug molecules have been failing in the final stages of clinical trials, resulting in the loss of valuable time a... Read More »
November 2018The global neuroendocrine tumor treatment market size was estimated at USD 1.51 billion in 2017 and is expected to register a CAGR of 10.4% during the forecast period. Increasing cases of neuroendocrine tumors (NETs) are expected to accelerate the demand for treatment options, thereby au... Read More »
November 2018The global paroxysmal nocturnal hemoglobinuria (PNH) treatment market size was valued at USD 2.24 billion in 2017. It is expected to exhibit a CAGR of 11.2% during the forecast period. Increasing adoption of novel therapeutics, rising geriatric population, and the emergence of biologics ... Read More »
October 2018The global Precision Medicine (Diagnostics/Therapeutics) Market size was valued at USD 40.0 billion in 2017 and is expected to exhibit a CAGR of 9.9% over the forecast period. Diagnostic and therapeutic precision medicines are among the most complex and helpful achievements of current sc... Read More »
October 2018The global lysosomal acid lipase deficiency (LAL-D) treatment market size was valued at USD 380 million in 2017. It is expected to exhibit a CAGR of 10.8% during the forecast period. Increasing uptake of enzyme replacement therapy, continued use of supportive care therapies, and high unm... Read More »
October 2018The global pharmaceutical cartridges market size was valued at USD 933.33 Million in 2017 and is expected to register a CAGR of 7.8% over the forecast period. Rising prevalence of chronic conditions, such as diabetes and arthritis, is expected to boost market growth over the next few yea... Read More »
October 2018The global vaginitis therapeutics market size was valued at USD 2.20 billion in 2017 and is anticipated to expand at a CAGR of 8.4% during the forecast period. Increasing awareness about women’s health, introduction of new drugs by key companies, and rising demand for improved heal... Read More »
October 2018The global blockbuster oncology brands market size was valued at USD 28.75 billion in 2017. Heightened adoption of cancer immunotherapies in developed regions along with continual expansion of indications with accelerated approvals granting these therapies first-line treatment status is ... Read More »
October 2018The global gaucher disease (GD) drugs market size was valued at USD 1.55 billion in 2017. It is anticipated to expand at a CAGR of 1.1% during the forecast period. Gaucher disease is an autosomal recessive metabolic disorder, with an average prevalence of 1 in 100,000 individuals. It is ... Read More »
October 2018The global pregnancy care products market size was valued at USD 22.39 million in 2017. Rising demand stemming from developing countries is one of the principal factors driving the global market towards growth. A gradual shift in trend from traditional home remedies for skincare during p... Read More »
October 2018The U.S. PRP and stem cell alopecia treatment market size was valued at USD 123.7 million in 2017 and is anticipated to exhibit a CAGR of 5.1% over the forecast period. Increase in number of people suffering from alopecia and rising awareness and adoption of novel treatment procedures ar... Read More »
October 2018The Asia Pacific biopharma excipients market size was estimated at USD 473.72 million in 2017. It is projected to progress at a CAGR of 6.63% during the forecast period. High R&D investments in biosimilars coupled with the patent expiration of top-selling biologics are anticipated to... Read More »
October 2018The artemisinin combination therapy market size was valued at USD 363.8 million in 2017. It is projected to expand at a CAGR of 8.5% during the forecast period. There has been a tremendous upsurge in the demand for artemisinin combination therapy (ACT) over the past few years following i... Read More »
October 2018The global botanicals market is anticipated to witness growth over the forecast period. From ages, natural products, extracts & nature-based products have been used as a form of treatment for various acute & chronic ailments. With time, various improvements have been made to the ...Read More »
The global migraine drugs market size was valued at USD 1.7 billion in 2017 and is expected to exhibit a CAGR of 18.0% during the forecast period. Increased uptake of novel drug classes, the launch of Calcitonin gene-related peptide (CGRP)-based therapies, and high unmet needs are some o... Read More »
September 2018The global psoriasis drugs market size was valued at USD 11.3 billion in 2016. It is anticipated to post a CAGR of 9.4% during the forecast period. Increasing awareness regarding treatment and rising demand for improved healthcare infrastructure are among the primary growth stimulants fo... Read More »
September 2018The global mouth ulcer treatment market size was valued at USD 937.5 million in 2017. It is expected to grow at a CAGR of 3.8% over the forecast period. Rising awareness regarding oral hygiene and increasing geriatric population is anticipated to drive the market during the forecast... Read More »
September 2018The global amyloidosis treatment market size was valued at USD 3.6 billion in 2017 and is anticipated to exhibit a CAGR of 7.2% over the forecast period. Increased adoption of novel targeted therapies and transplantations, emergence of biologics, and rising geriatric population are some ... Read More »
September 2018The global acne drugs market size was valued at USD 4.1 billion in 2017 and is anticipated to register a CAGR of 4.2% during the forecast period. The market is projected to exhibit moderate growth over the forecast period, which can be attributed to factors such as the emergence of biolo... Read More »
August 2018The global sickle cell disease treatment market size was valued at USD 2.1 billion in 2017 and is anticipated to exhibit a CAGR of 14.3% during the forecast period. Sickle cell disease (SCD) is a hereditary blood disorder characterized by abnormal, rigid, sickle-shaped red blood cells (R... Read More »
August 2018The global myeloproliferative disorders drugs market size was valued at USD 7.35 billion in 2017. It is expected to register a CAGR of 3.4% during the forecast period. The U.S. dominated was at the forefront of the seven major markets. The availability of novel drugs along with the prese... Read More »
August 2018The global myelodysplastic syndrome (MDS) drugs market size was valued at USD 1.3 billion in 2016 and is expected to register a CAGR of 9.7% over the forecast period. The market is primarily driven by emergence of novel therapeutics. Rising geriatric population, increasing incidence of n... Read More »
August 2018The global Crohn’s disease therapeutics market size was estimated at USD 3.8 billion in 2016 and is expected to register a CAGR of 2.4% during the forecast period. Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor dri... Read More »
August 2018The global cholera vaccines market size was estimated at USD 63.1 million in 2017 and will exhibit a CAGR of 8.2% during the forecast period. High disease incidence rate and increasing need for its prevention are some of the key factors expected to boost the market. The WHO Global Task F... Read More »
August 2018The global Duchenne Muscular Dystrophy (DMD) drugs market size was valued at USD 365 million in 2017. It is anticipated to register a CAGR of 41.3% during the forecast period. The disease is the most common form of muscular dystrophy affecting 16 to 20 infants per 100,000 live births. DM... Read More »
August 2018The global women’s health therapeutics market size was valued at USD 108.0 billion in 2017 and is expected to expand at a CAGR of 8.8% over the forecast period. Continuous rise in prevalence of chronic and lifestyle-associated disorders in women is likely to propel market growth. I... Read More »
July 2018The global biosimilars market size was valued at USD 4.36 billion in 2016. It is anticipated to exhibit a CAGR of 34.2% during the forecast period. The cost-effectiveness of biosimilar drugs and the high prevalence of chronic disorders globally are some major factors contributing to mark... Read More »
July 2018The global sarcoma drugs market size was valued at $703 million in 2017. It is expected to register a CAGR of 8.5% during the forecast period. Soaring adoption of novel drugs, the presence of strong developmental pipeline, rising incidence of soft tissue sarcomas (STS), and increasing R&... Read More »
July 2018The global hyperlipidemia drugs market size was valued at USD 19.3 billion in 2016. It is estimated to progress at a CAGR of 2.3% over the forecast period. Introduction of new guidelines that redefined at-risk patient groups and the emergence of novel drug classes promising better effica... Read More »
July 2018The global systemic lupus erythematosus market size was estimated at USD 1.87 billion in 2017. It is anticipated to register a CAGR of 7.0% over the forecast period. The market is estimated to gain traction with arrival of key pipeline agents, which promise higher efficacy than existent ... Read More »
July 2018The South East Asia nutraceutical excipients market size was estimated at USD 547.28 million in 2017. Recent advances in bioactive food components and functional foods used as nutrition supplements are anticipated to drive demand. The South East Asian (SEA) market is diversified in natur... Read More »
June 2018The global colorectal cancer therapeutics market size was valued at USD 8.6 billion in 2016, exhibiting a CAGR of 3.3% during the forecast period. Colorectal cancer (CRC) accounted for approximately 8.0% of the global cancer incidence in 2016, making it the third most common cancer ... Read More »
June 2018The global liver cancer drugs market size was valued at USD 424 million in 2016. It is expected to progress at a CAGR of 19.4% during the forecast period. The U.S. spearheaded the market among seven major countries. Availability of novel drugs, the presence of strong pipeline, and rising... Read More »
June 2018The global ovarian cancer drugs market size was valued at USD 1,030 million in 2016. It is expected to exhibit a phenomenal CAGR of 23.7% during the forecast period, with the U.S. at the forefront of the growth. Rising incidence of ovarian cancer owing to growing geriatric population and... Read More »
May 2018The global hepatitis therapeutics market size was estimated at USD 19.6 billion in 2016 and is anticipated to grow at a CAGR of 2.7% during the forecast period. Few prominent factors that are expected to boost the market are growing prevalence of viral hepatitis, rise in the number of au... Read More »
April 2018The global thalassemia market size was valued at USD 1.72 billion in 2016 and is estimated to expand at a CAGR of 10.8% during the forecast period. Large population, increase in awareness about available treatment options, and rise in demand for improved curative gene therapies are some ... Read More »
March 2018The global thyroid gland disorder treatment market size was valued at USD 1.97 billion in 2016 and is expected to register a CAGR of 3.2% during the forecast period. Rising incidence of hypothyroidism and growing awareness levels among individuals are key contributors to market growth. V... Read More »
March 2018The global vaccine contract manufacturing market size was valued at USD 1.8 billion in 2016 and is projected to expand at a CAGR of 9.3% during the forecast period. At present, apart from the safety and effectiveness of inoculations, the number of products developed per year is also an i... Read More »
February 2018The global rheumatoid arthritis therapeutics market size was valued at USD 20.3 billion in 2016. The market is anticipated to expand at a CAGR of 4.6% over the forecast period. Increasing prevalence of arthritis, growing acceptance of biopharmaceuticals, and the presence of well-defined ... Read More »
February 2018The global Breakthrough Therapy (BT) designation market size was valued at USD 44.1 billion in 2016 and is expected to grow at a CAGR of 14.1% during the forecast period. The BT designation is granted to drugs that bring about substantial improvement in disease conditions compared to exi... Read More »
January 2018The global smart pills market size was worth USD 779.4 million in 2016 and is anticipated to expand at a CAGR of 16.3% over the forecast period. High demand for minimally invasive procedures, an increase in focus on patient convenience, and technological development including miniaturiza... Read More »
January 2018The global pediatric vaccines market was estimated at USD 22.4 billion in 2016. An increase in government and non-government funding for the development of novel vaccines, along with initiatives for raising awareness about immunization, is likely to have a positive impact on market growt... Read More »
January 2018The global pharmerging market size was valued at USD 548.3 billion in 2016 and is expected to grow at a CAGR of 17.1% over the forecast period. The increasing geriatric population, increasing healthcare expenditure, increasing the number of private hospitals, and increasing disease burde... Read More »
December 2017The global angina pectoris drugs market size was valued at USD 8.5 Billion in 2016 and is expected to grow at a CAGR of 3.2% during the forecast period. The U.S. dominated the angina pectoris drugs market among the seven major countries. The global angina pectoris market is expected to b... Read More »
November 2017The global bipolar disorder market size was valued at USD 4.9 billion in 2016 and is expected to grow at a CAGR of 2.10% during the forecast period. Increasing prevalence of bipolar disorder, government support for generating awareness about the bipolar disorder, and technological advanc... Read More »
November 2017The global schizophrenia drug market size was valued at USD 6.8 billion in 2016 and is estimated to grow at a CAGR of 2.5% over the forecast period. Schizophrenia, a chronic disorder of the central nervous system, affects 1.0% of the global population or seven out of 1,000 individuals. T... Read More »
November 2017The U.S. specialty injectable generics market size was valued at USD 8.05 billion in 2016 and is expected to witness a lucrative CAGR of 14.9% over the forecast period. Increase in the prevalence of target diseases, such as cancer, hepatitis C, multiple sclerosis, and others, has resulte... Read More »
November 2017The global insomnia therapeutics market size was valued at USD 2.18 billion in 2016 and is expected to grow at a CAGR of 5.3% over the forecast period. Increasing prevalence of insomnia across the world, rising stress level, growing geriatric population, and increasing awareness about va... Read More »
October 2017The global polycystic ovarian syndrome treatment market size was valued at USD 3.3 billion in 2016 and is expected to grow at a CAGR of 5.0% over the forecast period. According to the research conducted by American Academy of Family Physicians, approximately 7% of women of reproductive a... Read More »
October 2017The global acute lymphocytic leukemia therapeutics market size was valued at USD 1.5 billion in 2016 and is expected to grow at a CAGR of 10.0%. Rise in incidence of Acute Lymphoblastic Leukemia (ALL) and increase in initiatives undertaken by public and private organizations are som... Read More »
October 2017The global vaccine adjuvants market size was valued at USD 308.99 million in 2016 and is anticipated to grow with a CAGR of 10.6%. Rising prevalence of cervical cancer, infectious diseases such as Human Papillomavirus (HPV), HIV, tuberculosis, etc., and other fatal diseases are expected ... Read More »
September 2017The global xerostomia therapeutics market size was estimated at USD 602.3 million in 2016. Increasing adoption of chemotherapy and radiotherapy in cancer treatment coupled with rising use of prescribed medications are some of the key factors expected to boost the xerostomia therapeutics ... Read More »
September 2017The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these dise... Read More »
August 2017The global melanoma therapeutics market size was valued at USD 4.2 billion in 2016 and is anticipated to witness a CAGR of 11.21% during the forecast period. The rising incidence of melanoma and other skin cancers is expected to accelerate the demand for anticancer agents. According to W... Read More »
August 2017The global superdisintegrants market size was valued at around USD 258.6 million in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Factors such as growing generic drugs market, geriatric and pediatric population who have difficulty in swallowing tablet/capsules ... Read More »
August 2017The global pneumonia therapeutics market size was estimated at USD 11.9 billion in 2016 and is anticipated to grow at a CAGR of 8.0% throughout the forecast period. Increasing incidence of pneumococcal disease is a high impact rendering driver. Over the years, there has been a significan... Read More »
July 2017The global cystic fibrosis therapeutics market size was estimated at USD 3.56 billion in 2016. Increasing prevalence of Cystic Fibrosis (CF) coupled with rising treatment rate is one of the key factors anticipated to propel the demand for these therapeutics over the forecast period. More... Read More »
June 2017The Middle East and Africa parenteral nutrition market size was valued at USD 203.6 million in 2016 and is expected to grow at a CAGR of 7.1% over the forecast period. Increasing natality rate, rising number of premature births, risk of malnutrition, and increasing prevalence of chronic ... Read More »
May 2017The global nanoparticles - metal & metal oxides market in healthcare was estimated at USD 25.86 billion in 2016. The presence of a substantial number of metal nanoparticle based medicines that are currently approved by the U.S. FDA is one of the key factors for estimated revenue. In ... Read More »
April 2017Global gout therapeutics market is expected to gain profitable progress over the forecast period owing to factors such as the development of newer therapies which can be used as the add-on therapies with the already available treatment for gout.... Read More »
March 2017The global Non-small Cell Lung Cancer (NSCLC) therapeutics market size was valued at USD 6.2 billion in 2016 and is projected to grow with a CAGR of 7.5% over the forecast period. This high growth is attributed to the increasing patient population, expected entry of several drugs, and ri... Read More »
March 2017The global osteoporosis drugs market size was accounted for USD 11.5 billion in 2015 and is expected to grow at a CAGR of 3.3% over the forecast period. The market is largely driven by a significant rise in the prevalence of this disorder globally. This unprecedented rise in the prevalen... Read More »
January 2017The global nanocapsules market size was valued at USD 1.9 billion in 2015 and is expected to witness an attractive CAGR of 7.9% over the forecast period. Nanocapsules are vesicular systems composed of polymer membrane encompassing an inner core of the desired substance at the nanoscale. ... Read More »
January 2017The Culturing or farming of aquatic animals like fishes, crustaceans, mollusks, algae, aquatic plants, and the other aquatic organisms in different types of water is termed as “Aquaculture”. The cultivation process involves nurturing of these aquatic organisms in the controll...Read More »
The global antiplatelet market is anticipated to grow rapidly during the forecast period. The major drivers for antiplatelet market are factors such as the proliferation of antithrombotic/anticoagulant drugs, increasing aging population, an increase in thrombotic events, and recent advan...Read More »
The global chemotherapy induced anemia market is anticipated to register growth over the forecast period.Anemia is a condition wherein there is a decrease in the total amount of red blood cells or haemoglobin in the blood. Haemoglobin is an essential part of the red blood cells and binds...Read More »
Osteoporosis disease is the most prevalent disease that occurs due to bone mineral density which causes heavy risk of fractures and bone fragility. The disease occurs mostly in spine, hip, shoulder and forearm.Hip fractures are most common as nearly one-third of patients lose mobility an...Read More »
The global bird flu treatment market is expected to register growth over the forecast period. Avian influenza (AI), can be commonly known as bird flu. It is an infectious viral disease of birds. It is generally found in ducks and geese which live in open rivers. Avian influenza virus can...Read More »
The global bronchitis treatment market is anticipated to witness growth over the forecast period. The major factor that propels the market growth includes a large patient pool. Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words,...Read More »
The Anticonvulsants are the diverse group of the pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder. They seem to act as mood stabilizers, and for th...Read More »
The global immunomodulators market accounted for USD 131.7 billion in 2015 and is expected to grow at a CAGR of over 5.8% during the forecast period. The increasing incidence of chronic diseases including asthma, cancer, allergic conditions, and multiple sclerosis is presumed to be the k... Read More »
December 2016The global multiple myeloma therapeutics market size was valued at USD 7.5 billion in 2015 and is projected to grow at a CAGR of 16.6% over the forecast period. The high growth is anticipated on account of the approval attained for the newer drugs in the market. In addition, the limited ... Read More »
November 2016The global doxorubicin market size was valued at USD 809.6 million in 2015 and is projected to grow at a CAGR of 6.4% over the forecast period. Increasing government intervention to support technological advancement in clinical oncology such as intravenous free therapy and digital m... Read More »
November 2016The global genitourinary drugs market accounted for USD 28.2 billion in 2015 and is anticipated to grow at a CAGR of over 0.8% during the forecast period. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, i... Read More »
November 2016The APAC Radiopharmaceuticals market was valued at USD 1.1 billion in 2015 and is expected to witness a CAGR of 10.9% over the forecast period. Radiopharmaceuticals are being extensively used for molecular imaging, which involves the use of these molecules as biomarkers for specific mole... Read More »
October 2016The global biological implants market was valued at USD 5,070.8 million in 2015 and is expected to exhibit a growth rate of 7.6% over the forecast period. With technological breakthroughs in the fields of regenerative medicine and tissue engineering, the market for biological implants is... Read More »
October 2016The global Human Immunodeficiency Virus (HIV)-1 therapeutics market was valued at USD 13.5 billion in the year 2015 and is estimated to grow at a CAGR of 1.4% from 2016 to 2025. The market growth can be linked to the surging incidence rate of HIV-1 infection, which unlike the death rate ... Read More »
October 2016The global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, ...Read More »
The global anti-tumor drugs market is expected to witness significant growth over the forecast period. The market growth may be attributed to increasing demand and continuous development in the field of medicine. However, high cost and the side effects associated with these drugs may act...Read More »
The global acute coronary syndrome therapeutic market demand is expected to witness considerable growth over the forecast period. ACS or Acute Coronary Syndrome refers to the set of conditions which occurs on account of decreasing flow of blood in coronary arteries owing to which the hea...Read More »
The global anti-obesity therapeutics market is forecasted to grow at a CAGR of above 20.0%. On account of increasing prevalence of obesity worldwide. Incidences of obesity are increasing fiercely over the past decades and it is often described as a global endemic, particularly in the dev...Read More »
The Arthroscopy market was valued at USD 4.0 billion in 2015 and is expected to witness a CAGR of 4.9% over the forecast period. Rising geriatric population is primarily driving the growth of the as this population bracket is most prone to injuries requiring arthroscopic procedures. ... Read More »
August 2016The North America Opioid Market was valued at USD 12.4 billion in 2015 and is expected to witness growth at a CAGR of 4.6% over the forecast period.... Read More »
August 2016The global Vaccine Market was valued at over USD 32.5 billion in 2015 and is expected to grow at a CAGR of 10.3% over the forecast period. The rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunization are the major factors boosting the m... Read More »
August 2016The global fondaparinux market was valued at USD 365.9 million in 2015 and is expected to witness a CAGR of 7.8% over the forecast period. The increasing base of health conscious population coupled with the presence of generic alternatives is estimated to boost market growth.... Read More »
July 2016The global empty capsules market was valued at USD 1.34 billion in 2015. Key factors responsible for the growth include the increasing geriatric population, the high demand for empty capsules in the pharmaceutical, nutraceutical, and cosmeceutical industries, and the growing consumer pre... Read More »
July 2016The global epilepsy drugs market was valued at USD 4,100 million in 2015. The expected launch of drugs currently in the pipeline, such as Ganaxolone by Marinus Pharmaceuticals, Inc., Perampanel by Eisai Co., Ltd., USL261 by Upsher Smith Laboratories, Inc., and YKP3089 by SK Life Sciences... Read More »
July 2016The global asthma therapeutics market accounted for USD 20.7 billion as of 2015 and is anticipated to exhibit a sluggish growth rate of 2.2% over the forecast period. This is attributed to the generic erosion faced by leading brands, such as Advair and Symbicort.... Read More »
July 2016Global liver diseases therapeutics market size was valued at USD 7,498.2 million in 2014. Key drivers of the market include increasing incidences of hepatocellular carcinoma and other liver diseases along with huge untapped needs of patients suffering from such diseases.... Read More »
July 2016Growing awareness related to smoking cessation therapy and smoking health hazards amongst the population are major drivers for the smoking cessation and nicotine de-addiction product market.... Read More »
June 2016The global geriatric medicine market was valued at nearly USD 540 billion in 2015. One of the key factors attributing to its rapid growth includes rapidly increasing geriatric population base.... Read More »
June 2016The global multiple sclerosis therapeutics market size was valued at USD 20.01 billion in 2015. The rising base of the target population suffering from relapsing-remitting and secondary progressive multiple sclerosis coupled with the increasing demand for novel potent drugs is a key fact... Read More »
May 2016The global viral conjunctivitis pipeline drugs market is expected to witness significant growth over the forecast period. Viral Conjunctivitis also known as “pinkeye”. It is a highly contagious acute conjunctival infection usually caused by adenovirus....Read More »
The global viral clearance market is expected to witness significant growth over the forecast period. Viruses are microscopic organisms that are contagious agents that reproduce only inside the living cells of other organisms. Viruses can infect all types of life forms right from a bacte...Read More »
The global vitamin tonics market is expected to witness significant growth over the forecast period. Vitamin tonics are known for their ability to strengthen and invigorate the body's tone of a human being. They are being utilized for the prevention and treatment of various deficiency co...Read More »
The global winter sports treatment market is expected to witness significant growth over the forecast period. Every year, millions of people drive to ski slopes, skating rinks, and frozen ponds to enjoy a few hours of skating, sledding, skiing, ice hockey, and the other winter sports. Al...Read More »
The global zoonotic disease treatment market is expected to witness significant growth over the forecast period. Zoonotic Disease is any disease spread from animals to people. Here are several zoonotic diseases like Lyme disease and malaria. Relatively less known zoonotic sicknesses comp...Read More »
The global liposomal doxorubicin market size was valued at USD 814.6 million in 2015 and is projected to grow at a CAGR of 6.2% during the forecast period. The market is experiencing growth due to rising breast & ovarian cancer cases and growing awareness regarding the bene... Read More »
January 2016The global anxiety disorders and depression treatment market size was valued at USD 15.2 billion in 2015 and is anticipated to show steady growth due to the increasing prevalence of anxiety disorder and depression worldwide. According to estimates published by the World Health Organizati... Read More »
December 2015Growing prevalence of conditions associated with pruritus such as atopic dermatitis, urticaria, and psoriasis is expected to serve the market as high impact rendering drivers. Moreover, the presence of high unmet medical needs and the subsequent introduction of new products such as REMIT... Read More »
March 2015The global antidiabetics market was valued at USD 41,609.7 million in 2013 and is expected to grow at a CAGR of over 10.0% during the forecast period. Growing worldwide prevalence of diabetes (both type I and type II) is expected to be a key driver for insulin and oral hypoglycemic drug ... Read More »
January 2015ITP (immune thrombocytopenic purpura) is recognized as a rare disease owing to its low prevalence rates. As per the U.S. FDA, the disease has an incidence rate of 3.3 cases per 100,000 in the country. Moreover, according to the European Medicines Agency (EMEA), in Europe, the incidence r... Read More »
December 2014The global artemisinin market is expected to witness substantial growth over the forecast period owing to its increasing application scope in the pharmaceutical industry. Demand for artemisinin has grown considerably over the past decade following the recognition of artemisinin-based com...Read More »
The global biopharmaceutical market is expected to witness significant growth over the forecast period. Biopharmaceuticals are drugs used for medical purposes and are produced by the extraction of proteins and nucleic acids direct from the biological source using biotechnology. Most biop...Read More »
The global non-small cell lung cancer market is expected to gain significant demand during the forecast period. Lung cancer is differentiated into two types as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Lung cancer is the uncontrolled growth of cells in the lun...Read More »
The global medical imaging reagents market is anticipated to grow significantly over the forecast period. Medical imaging reagents are compounds designed to improve the image created through imaging devices. Reagents allow doctors to analyze whether a tumor is benign or malignant and fac...Read More »
The global nanomedical devices and therapeutic market is expected to witness significant growth over the forecast period. Increasing prevalence of chronic diseases, growing R&D activities, rising awareness pertaining to minimally invasive surgical procedures, and the development of t...Read More »
Global top 10 drug delivery technologies market has introduction of advanced technologies such as novel intelligent inhalers and micro-needle transdermal patches as one of the high impacts rendering driver. Some other drivers for this market are growing demand for effective drug delivery...Read More »
The global hospital-acquired disease testing market has increasing morbidity rates worldwide due to infections, along with the prevalence of pathogens, bacterial, fungal & viral diseases, among its vital growth drivers. Another important driving force is increasing length of stay in ...Read More »
Rising prevalence of cardiovascular disorders, increasing geriatric population base coupled and growing need for repeat revascularization procedure are the major growth propellers of coronary artery bypass graft devices (CABG) market. Increasing incidences of coronary heart diseases resu...Read More »
The global cancer therapeutics and biotherapeutics market is anticipated to grow significantly over the forecast period. Cancer is a disease caused by uncontrolled and abnormal cell proliferation which invade or spread to other body parts and is known as a malignant tumor. As per the WHO...Read More »
Global anti-inflammatory peptides market is expected to grow over the forecast period owing to the increasing incidences of diseases such as autoimmune diseases, inflammatory bowel disease, multiple sclerosis, and psoriasis. The report published by the World Psoriasis Day in 2013, says t...Read More »
Insulin is one of the most important hormones secreted in human body. Insulin opens the door for glucose to enter into blood cells. Insufficient production of insulin by human body leads to stockpiling of sugar in blood cells which causes diabetes. ... Read More »
July 2014The global lifestyle drugs market is luring various pharmaceutical companies globally and is anticipated to grow substantially over the forecast period. Key drivers for this market are increasing use of these drugs by all age groups, rising demand to enhance life expectancy, and to reduc...Read More »
Insulin is a body hormone and is an internal secretion of the pancreas formed by a group of cells referred to as the islets of Langerhans. The primary functions of this hormone are to enable the entry of glucose into the cells and provide energy and to help maintain blood glucose levels ... Read More »
June 2014The global dilated cardiomyopathy market is anticipated to grow significantly over the forecast period. Dilated cardiomyopathy (DCM) is a cardiac disorder caused by enlargement of heart. The muscular walls of the heart become weak due to enlargement and hence heart is not able to pump bl...Read More »
The global BELVIQ market is anticipated to grow significantly over the forecast period. BELVIQ, a product of Arena Pharmaceuticals GmbH. is an FDA-approved prescription weight-loss medication that helps overweight and obese adults lose weight and keep it off. BELVIQ has to be taken along...Read More »
The global tissue sealants market is expected to grow over the forecast period owing to the increasing surgical procedure. Increase in the number of surgical interventions as a consequence of rising incidences of trauma conditions due to the rise in number of sports injuries, and increas...Read More »
The global cholangitis market is anticipated to grow significantly over the forecast period. Cholangitis is the term used for infection in the common bile duct of the individual. The bile duct is the tube that carries bile juice, which is helpful for digestion, from the liver to the inte...Read More »
The global autoimmune treatment market is anticipated to witness growth over the forecast period. Rising prevalence of autoimmune diseases is the major driver attributing towards the growth of the market. As per the statistics published by the National Institute of Health (NIH), around 2...Read More »
The global wound care sealants market is expected to experience a lucrative growth on account of increasing number of surgeries all over the world. Advancement in wound care products which include hydrocolloids, fibrin, collagen, hydrogels, rising awareness among the population about the...Read More »
Insulin is a hormone, which facilitates the entry of glucose into the blood cells. The body’s inability to produce an appropriate amount of insulin leads to accumulation of sugar in the bloodstream leading to a rise in blood sugar levels and eventually diabetes. ... Read More »
May 2014Genetic analysis refers to the study of DNA and RNA or the basic structure of genes for varied analytical purposes. Genetic analysis has emerged as an important tool in the fields of diagnostics, drug discovery, and biomedical research. It is helpful in determining the occurrence of dise...Read More »
The global contract research organization market is expected to witness significant growth over the forecast period. Any organization that provides support to the medical device industries, pharmaceutical firms, etc. in the form of outsourced research services on a contractual basis is c...Read More »
The global perennial allergic rhinitis market is expected to show a significant growth rate during the forecast period. Increasing demand for effective and potent drugs high prevalence of the disease, increasing respiratory disorders, and changing lifestyles such as smoking are the high ...Read More »
Increasing prevalence of genetic diseases such as Down syndrome, Edward syndrome, and Patau syndrome in new born and prenatal is the high impact rendering driver for the growth of prenatal & newborn genetic testing market. Increasing demand for prenatal & newborn genetic testing ...Read More »
Global Scleroderma diagnostics and therapeutics market is anticipated to witness growth during the forecast period. Increasing prevalence of scleroderma and rising incidences of genetic mutations coupled with drastic changes in the environment is the high impact rendering drivers. Accord...Read More »
The global neurometabolic disorders market is expected to grow at a lucrative rate during the forecast period owing to the increasing incidence of various neurometabolic disorders. The growing demand for rapid diagnostic techniques over current techniques due to factors such as long turn...Read More »
Global dyslipidemia drugs market is expected to witness lucrative growth over the forecast period owing to growing prevalence of lipid associated disorders and cholesterol abnormalities. These include triglyceride abnormalities and inability of the body to metabolize fats and biomolecula...Read More »
Deceptive representation of an original pharmaceutical and food product is referred to as counterfeiting. High growth of cheap and low-quality counterfeit products especially pertaining to the pharmaceutical and food industries have accelerated the rate of implementation of anti-counterf...Read More »
The global leukemia therapeutics market is expected to witness high growth during the forecast period due to rising incidences of chronic diseases worldwide. Leukemia is identified by the spread of disease (acute and chronic) commonly caused due to exposure to radiation, unhealthy lifest...Read More »
The global acute myeloid leukemia therapeutics market is anticipated to gain lucrative growth over the forecast period as a consequence of rising incidences of acute myeloid leukemia (AML)and its relapse cases across the globe. The increasing need for advanced therapeutics is also a high...Read More »
Contraception is more commonly known as fertility and birth control, which are described as methods to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum.... Read More »
January 2014The global schizoaffective disorders treatment market is expected to experience an upsurge due to rising torpid lifestyle, increasing healthcare spending and awareness, prevalence of chronic diseases, the new drugs in pipeline in the mental health sector, and availability of advanced hea...Read More »
The global metabolomics market is anticipated to grow significantly over the forecast period. The study of chemical processes involving metabolites is called metabolomics. The field of metabolomics study the chemical fingerprints left behind by biological (cellular) processes. Some of th...Read More »
The global gonorrhea diagnostic market is expected to witness a significant growth during the forecast period owing to the growing prevalence of the disease worldwide and unmet need in the faster diagnosis tools. According to the U.S. Center for Disease Control and Prevention (CDC), prev...Read More »
The global endocrinology drugs market is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of endocrine diseases. These diseases include endocrine gland associated disorders, such as Addison’s disease, gigantism, goiter, Cushing’...Read More »
The global small molecule targeted cancer therapy is expected to be a lucrative market due to its high adoption rates, minimal adverse effects, and high incidence rates of cancer. Patent expiration of the known drug, Glivec of Novartis, is expected to act as an opportunity for manufactur...Read More »
The global anti-counterfeit pharmaceuticals and cosmetics packaging market is expected to grow over the next six years owing to increasing rules and regulations and government initiatives to protect consumers from the use of harmful products. Personal care and cosmetic products are the t...Read More »
Global spinal fusion bone graft substitutes market is expected to grow substantially owing to increasing demand for minimally invasive surgeries coupled with growing geriatric population, which is correlated with the rising rates of conditions such as Degenerative Disc Disease (DDD), Kyp...Read More »
The global anti-cancer drug market is expected to grow on account of increasing multiple cancer incidences, especially in developed economies. Anti-cancer drug market revenues are expected to increase by 50% in the next five years owing to favorable regulatory scenarios mainly in the U.S...Read More »
The global cancer vaccines drug pipeline market is expected to witness significant growth over the forecast period. Rising vaccines usage combined with other therapies is expected to drive market growth over the forecast period. Growing occurrence of different types of cancer and the int...Read More »
The global combination drugs diagnostic market is expected to witness exponential growth over the coming seven years due to greater efficiency attached to the combination diagnosis and accelerated approval of drugs by the regulating authority. In addition, rising geriatric population bas...Read More »